Acremonium kiliense
Summary
The saprophytic fungus mold Acremonium kiliense, also referred to in the literature as Cephalosporium acremonium, can contaminate air, surfaces, and drinking water. Exposure to Acremonium/Cephalosporium spp. has been specifically associated with a range of respiratory and cutaneous allergic conditions including asthma, allergic rhinitis, hypersensitivity pneumonia, acute exogenous allergic alveolitis, chronic pulmonary morbidity, and atopic dermatitis. No allergenic molecules have been characterized from A. kiliense to date, however, an alkaline protease enzyme has been isolated which may have allergenic potential.
Route Of Exposure
Main
Exposure to fungi can occur via inhalation, skin contact, or ingestion.
Clinical Relevance
Fungal allergens can elicit respiratory and skin symptoms in sensitized patients, and can also activate the innate immune system and enhance inflammation caused by unrelated allergens (e.g. grass pollen). The prevalence of sensitization to molds is estimated to range from 3‒10% among the general population worldwide but may be higher in atopic individuals.
Fungal sensitization is found more often in patients with asthma and may represent a risk factor for developing asthma. A study in Chicago (USA) reported that mean levels of mold spores during the pollen season (March 21 to October 31 during four consecutive years), but not levels of tree, grass, or ragweed pollen, were significantly higher on days corresponding with asthma-related deaths than for days on which no deaths occurred (p<0.005).
In most clinical cases the exact etiological agent cannot be specified due to the morphological similarity of many species of Acremonium. Additionally, phylogenetic ambiguities may have based an unknown portion of the literature on Acremonium kiliense, other Acremonium spp., Cephalosporium spp., or Sarocladium kiliense. As a result, the actual incidence of various species of Acremonium/Cephalosporium/Sarocladium in the clinical setting is unknown, and likely to be under-represented.
A cross-sectional multivariate analysis of preschool children (<7 years of age) in Colombia (South America) identified exposure to Acremonium spp. as an indoor biological contaminant that could be associated with asthmatic respiratory symptoms. In the US, one patient within a cohort of 21 atopic patients with symptoms consistent with allergic rhinitis or asthma showed specific IgE against Acremonium strictum.
‘Humidifier lung’ has been proposed as an important cause of hypersensitivity pneumonia. One case report described a male ex-smoker (aged 60 years) who was hospitalized with progressive dyspnea and fever and diagnosed with acute respiratory tract infection. Shortly after discharge following successful treatment, the patient was readmitted with recurring symptoms, and diagnosed with hypersensitive pneumonitis with a positive specific precipitin reaction against antibody for Cephalosporium acremonium. The patient in this report recovered after treatment, and no relapse was observed after avoiding the use of a humidifier. Various other authors have also reported positive antigen-specific antibodies to Cephalosporium in patients with hypersensitivity pneumonitis, several of which were directly traced back to the use of a humidifier.
A case report from Germany described a patient (aged 24 years) diagnosed with acute exogenous allergic alveolitis with typical symptoms of unproductive cough, dyspnea on exertion, fever, loss of weight, headache, and limb pains. In this patient, precipitating antibodies were demonstrated against a range of molds including Cephalosporium acremonium, which were traced to pot plant earth and containers at the patient’s home.
Cephalosporium spp. were identified as the apparent antigenic source in two cases of significant chronic pulmonary morbidity where symptoms remitted during absence from the home. In Case 1 (female aged 33 years with persistent fever, myalgias, and dyspnea), the source was repeated flooding of the patient’s home with sewer water. Case 2 (female aged 36 years with intermittent coughing, myalgia, malaise, and dyspnea for several years) was traced to a contaminated humidifier. Both patients fully recovered after vacating their homes.
In a study evaluating the association between gut mycobiome and atopic dermatitis development in infants aged 9–12 months, the abundance of Acremonium spp. was considerably higher in individuals who had outgrown (recovered) versus those who persisted (still undergoing) (p=0.0023).
Occupational exposure to fungi and its association with allergy was assessed in a survey of employees at a museum in Warsaw (Poland). A total of 85% (88/103) workers reported one or more allergic symptoms including rhinitis (69%), conjunctivitis (70%), and skin symptoms (57%), while 30% of subjects reported developing these symptoms at work following contact with items potentially contaminated with fungi. The species most frequently isolated from investigated exhibits included Penicillium, Aspergillus, Cladosporium, Alternaria, Trichoderma, Acremonium, and Paecilomycese, and sensitization to at least one of these fungal allergens was reported in 30% of subjects.
Other topics
In immunocompetent individuals, Acremonium kiliense/Sarocladium kiliense can cause infections such as dermatophytoses, kerion, onicomycoses, keratitis, and mycetomas. Pathogenicity is usually related to inoculation of the fungus via a penetrating injury that often leads to a granuloma formation. However, in immunodeficient patients or those with underlying immunological disorders, the fungus can cause pneumonia, arthritis, osteomyelitis, endocarditis, peritonitis, meningitis, and sepsis, especially in the presence of risk factors such as prosthesis, catheters, immunosuppressive therapy, and anatomic disorders. These infections are difficult to treat and may have a fatal outcome.
A nosocomial outbreak of fungemias in Chile, involving 65 chemotherapy patients in 8 hospitals with mild clinical manifestations, was attributed to Sarocladium kiliense. Reports of superficial and subcutaneous Sarocladium infections have been reported worldwide. Opportunistic agents including Acremonium kiliense have also been detected in patients with phagocyte disorders. A case report described pneumonia caused by A. kiliense as the first clinical manifestation of chronic granulomatous disease in a child aged 4 months.
Cross-Reactivity
No published data is currently available.
References
- Pastorino AC, Menezes UP, Marques HH, Vallada MG, Cappellozi VL, Carnide EM, et al. Acremonium kiliense infection in a child with chronic granulomatous disease. Braz J Infect Dis. 2005;9(6):529-34.
- Summerbell RC, Gueidan C, Schroers HJ, de Hoog GS, Starink M, Rosete YA, et al. Acremonium phylogenetic overview and revision of Gliomastix, Sarocladium, and Trichothecium. Stud Mycol. 2011;68:139-62.
- Perdomo H, Sutton DA, García D, Fothergill AW, Cano J, Gené J, et al. Spectrum of clinically relevant Acremonium species in the United States. J Clin Microbiol. 2011;49(1):243-56.
- Yao L, Wang H, Wan Z, Li R, Yu J. The High Diversity and Variable Susceptibility of Clinically Relevant Acremonium-Like Species in China. Mycopathologia. 2019;184(6):759-73.
- Ranjbar-Mobarake M, Nowroozi J, Badiee P, Mostafavi SN, Mohammadi R. Fatal disseminated infection due to Sarocladium kiliense in a diabetic patient with COVID-19. Clin Case Rep. 2021;9(9):e04596.
- Fernández-Silva F, Capilla J, Mayayo E, Sutton D, Guarro J. Combination therapy in the treatment of experimental invasive fungal infection by Sarocladium (Acremonium) kiliense. Int J Antimicrob Agents. 2014;44(2):136-9.
- Fincher RM, Fisher JF, Lovell RD, Newman CL, Espinel-Ingroff A, Shadomy HJ. Infection due to the fungus Acremonium (cephalosporium). Medicine (Baltimore). 1991;70(6):398-409.
- Van Heyningen SS, D.S. A new alkaline protease from Acremonium kiliense. Biochemical Journal. 1971;125(4):1159-60.
- CABI. Acremonium kiliense Wallingford, UK2021 [cited 24.01.22]. Available from: https://www.cabi.org/isc/datasheet/2976.
- Twaroch TE, Curin M, Valenta R, Swoboda I. Mold allergens in respiratory allergy: from structure to therapy. Allergy Asthma Immunol Res. 2015;7(3):205-20.
- Arvanitidou M, Kanellou K, Constantinides TC, Katsouyannopoulos V. The occurrence of fungi in hospital and community potable waters. Lett Appl Microbiol. 1999;29(2):81-4.
- Madsen AM, Crook B. Occupational exposure to fungi on recyclable paper pots and growing media and associated health effects – A review of the literature. Science of The Total Environment. 2021;788:147832.
- Latz MAC, Kerrn MH, Sørensen H, Collinge DB, Jensen B, Brown JKM, et al. Succession of the fungal endophytic microbiome of wheat is dependent on tissue-specific interactions between host genotype and environment. Science of The Total Environment. 2021;759:143804.
- Gonçalves AB, Paterson RR, Lima N. Survey and significance of filamentous fungi from tap water. Int J Hyg Environ Health. 2006;209(3):257-64.
- Schaffer N, Seidmon EE, Bruskin S. The clinical evaluation of air-borne and house dust fungi in New Jersey. The Journal of allergy. 1953;24 4:348-54.
- Solomon WR. A volumetric study of winter fungus prevalence in the air of midwestern homes. J Allergy Clin Immunol. 1976;57(1):46-55.
- Targonski PV, Persky VW, Ramekrishnan V. Effect of environmental molds on risk of death from asthma during the pollen season. Journal of Allergy and Clinical Immunology. 1995;95(5):955-61.
- Herrera AB, Rodríguez LA, Niederbacher J. [Biological pollution and its relationship with respiratory symptoms indicative of asthma, Bucaramanga, Colombia]. Biomedica : revista del Instituto Nacional de Salud. 2011;31 3:357-71.
- Beezhold DH, Green BJ, Blachere FM, Schmechel D, Weissman DN, Velickoff D, et al. Prevalence of allergic sensitization to indoor fungi in West Virginia. Allergy Asthma Proc. 2008;29(1):29-34.
- Tomoda Y, Murakami S, Kawaguchi K, Orihashi T, Tanaka K. Humidifier lung. QJM: An International Journal of Medicine. 2019;112(5):367-8.
- Popp W, Braun O, Zwick H, Rauscher H, Ritschka L, Flicker M. Detection of antigen-specific antibodies on lung tissue in a patient with hypersensitivity pneumonitis. Virchows Arch A Pathol Anat Histopathol. 1988;413(3):223-6.
- Suda T, Sato A, Ida M, Gemma H, Hayakawa H, Chida K. Hypersensitivity Pneumonitis Associated With Home Ultrasonic Humidifiers. CHEST. 1995;107(3):711-7.
- Patterson R, Fink JN, Roberts M, Kelly JF, Sommers HM. Antibody activity in sera of patients with humidifier disease: studies of the water supply as a source of antigens. J Allergy Clin Immunol. 1978;62(2):103-8.
- Patterson R, Fink JN, Miles WB, Basich JE, Schleuter DB, Tinkelman DG, et al. Hypersensitivity lung disease presumptively due to <em>Cephalosporium</em> in homes contaminated by sewage flooding or by himidifier water. Journal of Allergy and Clinical Immunology. 1981;68(2):128-32.
- Velcovsky HG, Graubner M. [Allergic alveolitis following inhalation of mould spores from pot plant earth (author's transl)]. Dtsch Med Wochenschr. 1981;106(4):115-20.
- Mok K, Suratanon N, Roytrakul S, Charoenlappanit S, Patumcharoenpol P, Chatchatee P, et al. ITS2 Sequencing and Targeted Meta-Proteomics of Infant Gut Mycobiome Reveal the Functional Role of Rhodotorula sp. during Atopic Dermatitis Manifestation. Journal of Fungi. 2021;7(9):748.
- Wiszniewska M, Walusiak-Skorupa J, Pannenko I, Draniak M, Palczynski C. Occupational exposure and sensitization to fungi among museum workers. Occup Med (Lond). 2009;59(4):237-42.
- Bougnoux M-E, Brun S, Zahar J-R. Healthcare-associated fungal outbreaks: New and uncommon species, New molecular tools for investigation and prevention. Antimicrobial Resistance & Infection Control. 2018;7(1):45.
- Orsini M, Otaíza F, Vega P, Hederra LM, Pidal P, Salas V, et al. [Outbreak of fungemias by Sarocladium kiliense in eight public hospitals per intrinsic contamination of ondansetron intravenous]. Rev Chilena Infectol. 2018;35(4):363-70.
- allergome.org. Acr ki 2021 [cited 2022 24.01.22]. Available from: http://www.allergome.org/script/search_step2.php.
- Balenga NA, Klichinsky M, Xie Z, Chan EC, Zhao M, Jude J, et al. A fungal protease allergen provokes airway hyper-responsiveness in asthma. Nature Communications. 2015;6(1):6763.
- Kauffman H, Tomee C, Riet M, Timmerman A, Borger P. Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production. The Journal of allergy and clinical immunology. 2000;105:1185-93